Page last updated: 2024-09-04

mk 767 and ziprasidone

mk 767 has been researched along with ziprasidone in 1 studies

Compound Research Comparison

Studies
(mk 767)
Trials
(mk 767)
Recent Studies (post-2010)
(mk 767)
Studies
(ziprasidone)
Trials
(ziprasidone)
Recent Studies (post-2010) (ziprasidone)
320101,068254362

Protein Interaction Comparison

ProteinTaxonomymk 767 (IC50)ziprasidone (IC50)
D(2) dopamine receptorHomo sapiens (human)0.005
Aspartate aminotransferase, cytoplasmicHomo sapiens (human)5.39
DRattus norvegicus (Norway rat)0.1514
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.1514
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.1514
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.1514
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.1514
Alpha-1D adrenergic receptorHomo sapiens (human)0.011
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0004
Alpha-1A adrenergic receptorHomo sapiens (human)0.011
Alpha-1B adrenergic receptorHomo sapiens (human)0.011
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.2301

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morphy, R; Rankovic, Z1

Reviews

1 review(s) available for mk 767 and ziprasidone

ArticleYear
Designed multiple ligands. An emerging drug discovery paradigm.
    Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors

2005